Faculty

  • Athena Poppas

    Vice President American College of Cardiology
    USA

    Read more

  • Jereon
    Bax

    Immediate Past President
    European Society of Cardiology
    The Netherlands

    Read more

  • Robert A. Levine

    Harvard Medical School
    USA

    Read more

  • Dipti Itchhaporia

    American College of Cardiology
    USA

    Read more

  • Robert Harrington

    President
    American Heart Association
    USA

    Read more

  • William J. McKenna

    University College London
    UK

    Read more

  • Karen
    Sliwa

    President
    World Heart Federation
    South Africa

    Read more

  • Robert J. Siegel

    Cedars-Sinai Medical Center, UCLA
    USA

    Read more

  • Amir
    Lerman

    Mayo Clinic
    USA

    Read more

  • Holger
    Thiele

    Heart Center Leipzig, University of Leipzig
    Germany

    Read more

  • Gregory Schwartz

    VA Medical Center & University of Colorado
    USA

    Read more

Athena Poppas

Vice President American College of Cardiology USA

Jereon
Bax

Immediate Past President
European Society of Cardiology
The Netherlands

Robert A. Levine

Harvard Medical School USA

Dipti Itchhaporia

American College of Cardiology USA

Robert Harrington

President
American Heart Association
USA

William J. McKenna

University College London UK

Biography

William McKenna is Canadian (BA – Yale, MD – McGill). He is CEO & Medical Director, Heart Hospital, HMC. Previously he established the Inherited Cardiac Disease clinic at St George’s Hospital and then at the Heart Hospital – University College London. He is also Associate Dean for Research (Weill Cornell Medicine-Qatar), Emeritus Professor of Cardiology (UCL) & Adjunct Professor in CV Medicine (Yale). His main interests have been in clinical and basic research of the cardiomyopathies. His recent work has contributed to the identification of disease-causing genes in HCM, DCM and ARVC, to the establishment of new diagnostic criteria within the context of familial disease, and to the establishment of algorithms to identify patients at high risk of sudden death. He has published >500 research papers in peer review journals.

Karen
Sliwa

President
World Heart Federation
South Africa

Biography

Karen Sliwa is widely recognised as a world expert in cardiovascular diseases (CVDs), with a particular interest in reducing mortality in women with cardiovascular disease (CVD) in maternity. She has contributed to better understanding on the pathophysiology, treatment options and awareness of peripartum cardiomyopathy (PPCM), a global disease particularly prevalent in African populations.

She leads several inter-Africa research projects, which have had a major impact for creating knowledge about CVDs common in Africa, leading to changes in policy.   Her considerable experience in setting up simple, cost-effective registries and web-based data entry platforms have had a major impact on planning several innovative research projects and has facilitated the training of physicians from several African countries, including Mozambique, Nigeria, Cameroon, Uganda and Tanzania. Her research from bed-to-bench-to-bedside population studies have led to a much better understanding of CVDs in pregnant women and to improved care.

Professor Sliwa leads several high-profile special interest groups including a dedicated EORP Working Group on PPCM of the Heart Failure Association of European Society of Cardiology. Over her distinguished career she has served in many notable roles, including that of President of the South African Heart Association (2014-2016) and, currently, as President of the World Heart Federation (2019-2020).

Robert J. Siegel

Cedars-Sinai Medical Center, UCLA USA

Biography

Internationally recognized as one of the leading experts in the field of cardiovascular ultrasound, Robert J. Siegel, MD, specializes in cardiovascular ultrasound, including transthoracic, transesophageal and intravascular methodologies.  Siegel’s research interests include valvular heart disease, therapeutic applications of ultrasound energy, 2D and 3D transesophageal echocardiography for the guidance and monitoring of percutaneous procedures such as mitral valve repair and aortic valve replacement, and intraoperative echocardiography.  In addition, he is involved with clinical research studies related to the diagnosis, assessment and management of patients with Marfan syndrome and other aortopathies as well as hypertrophic cardiomyopathy and pericardial and valvular heart disease.  Siegel is on the editorial board of two cardiovascular journals.  He has edited three textbooks on ultrasound-related topics, and he is a reviewer for more than a dozen cardiovascular journals.  Siegel has authored over 350 peer-reviewed scientific papers related to cardiovascular medicine.  He is also a contributing author to more than 20 cardiovascular textbooks.  Siegel is a fellow in the American College of Cardiology, and has previously served as the President of the California Chapter.  He is also a co-chair of the American College of Cardiology 2014 annual meeting, co-chair of the National Marfan Foundation 2013 annual meeting and a previous president of the Los Aneles Society of Echocardiography.  He has been active in numerous cardiovascular societies, including the American Heart Association, the American College of Cardiology and the American Society of Echocardiography.

Amir
Lerman

Mayo Clinic USA

Biography

Amir Lerman, MD. Is an endowed named Barbara Lips professor of medicine and a consultant in the department of cardiovascular disease at the Mayo graduate school of medicine. Dr. Lerman serves as an associate chair of the department of Cardiology and the Director of the cardiovascular research center at Mayo Clinic and the medical director of the chest pain and coronary physiology clinic. Dr. Lerman serves as the Director Mayo-Israeli start-up companies initiative and on the faculty member of the Merage Institute for medical innovation.  Dr. Lerman graduated from the Technion school of Medicine in Haifa Israel and completed his training in internal medicine, cardiovascular diseases and invasive cardiology at the Mayo Clinic. Dr. Leman interest is coronary physiology and imaging, regenerative medicine, innovative technologies and digital health. Dr. Lerman published more than 650 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research.

Holger
Thiele

Heart Center Leipzig, University of Leipzig Germany

Biography

Holger Thiele is the Medical Director of the Department of Internal Medicine/Cardiology at the Heart Center Leipzig at University of Leipzig which is one of the largest heart centers in Europe. He is full professor of cardiology at the University of Leipzig.

His main research interests are acute myocardial infarction, acute heart failure, cardiogenic shock, mechanical circulatory support, acute cardiovascular care, interventional cardiology and structural heart disease.

Professor Thiele has published over 500 articles in international scientific journals such as the New England Journal of Medicine, The Lancet, JAMA, Circulation, JACC, and the European Heart Journal with a cumulative impact factor of >4000. He has received multiple awards from the German Society of Cardiology and other organisations.

Gregory Schwartz

VA Medical Center & University of Colorado USA

Biography

Gregory G. Schwartz, MD, PhD, is Professor of Medicine (Division of Cardiology) at the University of Colorado. He is also Chief of Cardiology at the Rocky Mountain Regional VA Medical Center in Aurora, Colorado (USA).

Dr Schwartz graduated from Brown University in Providence, RI with a degree in Biomedical Engineering, and then received PhD and MD degrees from Duke University in Durham, NC. He completed residency in Internal Medicine at the University of Colorado and fellowship in Cardiology at the University of California San Francisco (UCSF), where he served on the faculty as Assistant and Associate Professor before assuming his present position.

Dr Schwartz’ clinical research has focused on trials of lipid and metabolic interventions in coronary heart disease, including the placebo-controlled cardiovascular outcomes trials that established the efficacy of intensive statin treatment (MIRACL, 2001) and PCSK9 inhibition (ODYSSEY OUTCOMES, 2018) after acute coronary syndrome. Among current activities, Dr Schwartz is Chair of the VA Cooperative Study “VA-IMPACT” testing the cardiovascular efficacy of metformin in pre-diabetes. In basic research, Dr. Schwartz directs a swine physiology laboratory that investigates translational questions in myocardial energy metabolism and ischemic protection.